市场调查报告书
商品编码
1574144
放射学人工智慧 (AI) 市场:2024-2029 年预测Artificial Intelligence (AI) in Radiology Market - Forecasts from 2024 to 2029 |
预计放射学市场中的人工智慧在预测期内将以 30.45% 的复合年增长率增长,从 2024 年的 22.7561 亿美元市场规模增长到 2029 年的 85.96802 万美元。
人工智慧 (AI) 中的深度学习演算法在基于视觉的应用中得到了完善。随着变分自动编码器和卷积类神经网路技术的实现,医学影像分析领域正在迅速扩展。由于测量的方便性,X光相片品质的传统定性评估有所不同。此外,人工智慧技术在分析影像资讯中包含的机械上困难的资讯模式方面变得越来越先进。例如,在放射学中,人工智慧演算法可以被设计来测量特定的放射线摄影特性,例如肿瘤的 3D 形状、每个像素的纹理以及肿瘤内的像素强度。
X 光照相术可以让有执照的医生研究临床图片和套件说明,以及识别和统一疾病,从而使他们能够检测、识别和监测疾病。其评估需要大量的专业知识和经验,有时容易受到意见的影响。与这种定性和主观评估相反,人工智慧非常擅长自动执行客观的数值分析,同时识别影像资料中的微妙模式。部署人工智慧来支援和协助乳房X光摄影医生将实现更准确和可重复的放射学评估。该应用程式为未来几年和几十年放射学市场人工智慧的进一步开拓打开了大门。
基于人工智慧的体积肿瘤分割可以提高所有脑肿瘤和其他神经系统癌症的识别和检测,具有极高的准确性和一致性。该系统还可以透过 MRI 扫描自动识别脑肿瘤。这些策略对于以可重复和公正的方式提供准确的诊断和评估肿瘤对治疗的反应将具有无价的价值。这种神经治疗的另一个使用案例是使用人工智慧来预测治疗结果,这有助于利用最佳策略。背景 机器学习已被用来根据 MR 影像的血液容积分布资料来预测病患的生存率。
例如,2023 年 2 月,放射筛检人工智慧平台 Avicenna 筹集了 700 万欧元的 A 轮融资,使其资本基础达到 1,000 万欧元。此阶段采用基于影像的深度学习来识别和评估放射学研究设施中危及生命的疾病。 电脑断层扫描影像用于在诊断前优先考虑有症状的患者。 Avicenna.AI 提供两种变体。一是心臟病发作的迹象和可能性,二是脑损伤和中风的可能性。该平台帮助放射科医师确定患者的生命是否受到威胁。
由于医疗和生物技术行业的研究支出和开发不断增加,预计亚太地区将在放射学市场的人工智慧中占据重要份额。此外,这些地区预计的大量患者数量将增加对更好的癌症治疗基础设施的需求,从而推动医疗保健行业的成长并促进区域层级的市场开拓。亚太地区也正在投资医疗保健以推动新技术,特别是在新兴经济体。
该地区的经济体越来越注重建立健康的医疗保健系统,以实现患者的早期诊断和早期治疗。此外,随着各大主要企业都计划在亚太国家扩大和建设设施,该地区的市场在未来几年可能会成长。例如,2023年5月,该领域的世界领导者、基于人工智慧的放射学公司Annalise.ai在印度清奈设立了第一个中心。透过这项策略倡议,Annalize 继续渗透到世界舞台,在亚洲等成熟市场和新兴市场开展业务。该中心专注于研究和商业化新产品,将先进的成像资料和电脑科学相结合,提供完整的人工智慧解决方案来支援临床决策。
为什么要购买这份报告?
公司使用我们的报告的目的是什么?
产业与市场考量、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开拓、竞争影响
The AI in radiology market is projected to grow at a CAGR of 30.45% during the forecast period, reaching a total market size of US$8,596.802 million by 2029, up from US$2,275.610 million in 2024.
Deep learning algorithms in artificial intelligence (AI) have been perfected in vision-based applications. The medical image analysis domain is expanding rapidly with the realization of variational autoencoders and convolutional neural network techniques. Traditional qualitative assessments for radiographic qualities differ since the measure is easy to perform. Moreover, AI techniques are more advanced at analyzing mechanically difficult information patterns in imaging information. For instance, in radiology, AI algorithms could be designed to measure specific radiographic characteristics, such as the 3D shape of a tumor, every pixel's texture, and pixel intensity within the tumor.
X-ray radiography is when licensed medical doctors study clinical photos and kit a statement or identify and single out diseases that allow disorders to be detected, identified, and monitored. That assessment requires a lot of expertise and experience, which is sometimes susceptible to opinion. In contrast to this qualitative, subjective evaluation, AI is extremely good at identifying subtle patterns in imaging data while automatically providing an objective numerical analysis. Implementing AI to support and assist mammogram physicians can result in more precise and reproducible radiological assessments. This application is opening the door to further development into AI in the radiology market in years or decades to come.
Working off of volumetric tumor segmentation, AI can improve identification and detection across all brain tumors and other neurological cancers with superior accuracy and consistency. The system will also automatically identify brain tumors on MRI scans. These strategies can be extremely valuable in providing precise diagnoses and assessing the tumor response to treatment in a reproducible and unbiased manner. Another use case in this neurological treatment is the prediction of outcomes using AI, which can assist in utilizing the best strategy. Background Machine learning has been used to predict survival among patients based on blood volume distribution data from MR imaging.
For instance, in February 2023, Avicenna, an AI platform for radiology screening, raised €7 million in a series A venture, bringing its capital base to €10 million. The stage employs image-trained profound learning to recognize and evaluate life-threatening ailments in radiology research facilities. It uses CT scan imaging to prioritize patients with symptoms before diagnosis. Avicenna.AI offers two variations: one for heart attack indications and chance and another for brain damage and stroke chance. The platform assists radiologists in deciding if a patient's life is threatened.
Asia Pacific is projected to hold substantial shares of AI in the radiology market owing to a rise in research spending and development in the medical and biotech industries. Moreover, the expected large number of patients in these areas will increase the demand for better cancer treatment infrastructure, propelling healthcare sector growth and aiding market development at a regional level. Asia Pacific has also seen investment in the healthcare sector, especially in emerging economies, to advance newer technologies.
The region's economies are increasingly focusing on creating a sound healthcare system for early patient diagnosis and treatment. In addition, various key companies are focusing on advancing their reach to Asia Pacific countries by building their facilities, leading to the regional market's growth in the coming years. For instance, in May 2023, Annalise. ai, an AI-based radiology company that is a global leader in the field, established its first Indian center in Chennai. Through this strategic move, Annalise continues penetrating the world arena with its presence in established and emerging markets like Asia. This translates into a center that specializes in the research and commercialization of new products containing advanced imaging data coupled with computer science that together results in complete AI solutions to support clinical decision-making.
Reasons for buying this report:-
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence